Patient Outcomes That Attract Investment | LSI Europe '25

Investment leaders from Watershed Therapeutics, Earlybird Health, and Segulah Medical Acceleration discuss which patient outcomes are most compelling to investors, offering strategic insights for medtech companies seeking funding in this interactive workshop session.

LSI USA ‘26 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

March 16th - 20th, 2026  Waldorf Astoria, Monarch Beach Register arrow